The proportion of patients completing treatment without dose reduction was 21.2% in the DI group versus 48.6% in the non-DI group—a numerically meaningful difference that did not reach statistical significance.
← all excerpts
Clinical impact of diverting ileostomy and high-output stoma on adjuvant chemotherapy for rectal cancer: a retrospective cohort study.
1
—
—